Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Introduction
Surgical resection is the standard therapy for nonmetastatic renal cell carcinoma (RCC) and is often curative [1]. However, in 20–40% of patients with localized disease RCC will recur, and recurrence is associated with risk factors such as pathologic evidence of invasion of the renal capsule, perinephric fat, or renal vein, or lymph node involvement [2].
There is no generally accepted adjuvant treatment for RCC [3], and results for the role of postoperative radiotherapy and more recently adjuvant sunitinib have been controversial [4]. For adjuvant radiotherapy, some of the studies were performed using outdated treatment planning and delivery techniques, with one study closing prematurely owing to a high rate of complications [5]. The most common side effects during treatment were nausea and vomiting, but late toxicity including small bowel stenosis and bleeding has been reported and is associated with morbidity and mortality [6].
Clinical data supporting the efficacy of adjuvant radiation are limited and based mostly on retrospective analyses or small randomized control trials. The optimal treatment remains uncertain as there is insufficient information to make evidence-based decisions on the use of adjuvant radiotherapy. In addition, evaluation of the efficacy of modern radiotherapy techniques is needed for RCC.
Here we report a systematic review and meta-analysis evaluating the efficacy of adjuvant radiation therapy in patients with nonmetastatic RCC.
Section snippets
Search strategy
This analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines [7]. We performed a systematic literature search of Cancerlit (host: Ovid), Medline (host: PubMed), Scopus, and Cochrane databases from database inception to January 2017. The searches used the keywords: kidney, cancer, carcinoma, hypernephroma, radiotherapy, adjuvant, and postoperative or related terms in different combinations, such as (renal OR kidney) AND Cancer AND
Evidence synthesis
Of the 5052 abstracts initially identified, 4993 were excluded and 59 full-text articles were retrieved for detailed evaluation. Forty-seven articles were excluded because they did not meet the inclusion criteria, including 37 review articles and ten articles on non-adjuvant radiotherapy. From the remaining 12 publications, two duplicate articles were excluded [9], [10]. In the remaining ten articles, two additional studies were identified from the reference lists. As a result, 12 studies were
Discussion
The present study suggests that adjuvant radiation therapy for patients with nonmetastatic RCC after nephrectomy is not associated with an improvement in OS or DFS, although the results suggest an improvement in LRR.
The risk of relapse after radical nephrectomy for local or locoregional RCC can be as high as 40%. Given such a high risk of relapse and the subsequent risk of cancer-related mortality, identification of effective adjuvant treatment is desirable. Predictors of relapse include RCC
Conclusions
The studies reviewed do not suggest that adjuvant radiation for patients with nonmetastatic RCC improves either OS or DFS. However, improvement in LRR was observed. Contemporary prospective studies with newer radiation planning techniques may be able to demonstrate better efficacy and lower toxicity and should be considered. At present, adjuvant radiation therapy cannot be recommended outside of a clinical trial.
This study was presented at the 2015 ESMO-ECCO meeting as a poster highlight.
Author
References (34)
- et al.
Updated European Association of Urology guidelines regarding adjuvant therapy for renal cell carcinoma
Eur Urol
(2017) - et al.
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Lancet
(2016) - et al.
Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group
Int J Radiat Oncol Biol Phys
(1987) - et al.
The value of postoperative irradiation in renal cell cancer
Radiother Oncol
(1992) - et al.
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system
J Urol
(2005) - et al.
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma
J Urol
(1998) - et al.
Radiotherapy for renal-cell carcinoma
Lancet Oncol
(2014) - et al.
Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Ann Oncol
(2012) - et al.
Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma
J Urol
(2002) - et al.
Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: a study of the GETUG group
Eur J Cancer
(2018)